TD Cowen Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $12
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy and lowers the price target from $14 to $12.
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy and lowers the price target from $14 to $12.